Pilot Neurobehavioral Therapy for Functional Neurological Disorder
ConditionFunctional Neurological Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorRhode Island Hospital
About this trial
The goal of this pilot randomized clinical trial is to learn if Neurobehavioral Therapy (NBT) works to treat motor functional neurological disorder (mFND) (also referred to as functional motor disorder).
The main questions it aims to answer are:
* Does NBT lower mFND symptoms? * Does NBT lower common co-occurring symptoms and improve functioning?
Researchers will compare NBT to standard medical care (SMC).
Participants will be randomized to receive either:
* 12 weekly sessions of NBT, along with their SMC, * or continue receiving their SMC as provided by their treating clinicians. * all participants. regardless of group assignment, will complete a total of five in-clinic visits at the following time points: Baseline, 6 weeks, 12 weeks, 8 Months and 12 Months for self-report surveys to assess functional status, quality of life and mFND symptoms.
Eligibility criteria
Qualifiers
Individuals diagnosed with Motor Functional Neurological Disorder (mFND)
Individuals aged 18-70 years
At least 1 mFND symptom during the year prior to enrollment
Disqualifiers
Current or past year self-injurious behavior
Current suicidality (PHQ-9 question 9 rated as 1 or above)
Current or past year psychosis
Pending litigation or current application for long term disability
Trial design
Treatments tested in this trial
- Neuro-behavioral Therapy
- Standard Medical Care (SMC)
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov